Published in
Taylor and Francis Group, Annals of Medicine, 1(46), p. 18-23, 2013
DOI: 10.3109/07853890.2013.853369
Links
Tools
Systemic metabolic markers and myocardial glucose uptake in type 2 diabetic and coronary artery disease patients treated for 16 weeks with rosiglitazone, a PPARγ agonist
Journal article published in 2013 by
Robert M. Badeau,
Miikka-Juhani Honka 
,
Riikka Lautamäki,
Murray Stewart,
Antti J. Kangas,
Pasi Soininen,
Mika Ala-Korpela,
Pirjo Nuutila
,
Riikka Lautamäki,
Murray Stewart,
Antti J. Kangas,
Pasi Soininen,
Mika Ala-Korpela,
Pirjo Nuutila
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 